Avidity Biosciences Inc (RNA)
50.00
-2.55
(-4.85%)
USD |
NASDAQ |
Nov 14, 16:00
49.98
-0.02
(-0.04%)
After-Hours: 16:58
Avidity Biosciences Profit Margin (Quarterly): -3.46K% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -3.46K% |
| March 31, 2024 | -1.94K% |
| December 31, 2023 | -2.76K% |
| September 30, 2023 | -1.86K% |
| June 30, 2023 | -2.03K% |
| March 31, 2023 | -2.35K% |
| December 31, 2022 | -1.82K% |
| September 30, 2022 | -1.76K% |
| June 30, 2022 | -2.10K% |
| March 31, 2022 | -1.91K% |
| December 31, 2021 | -2.08K% |
| Date | Value |
|---|---|
| September 30, 2021 | -1.35K% |
| June 30, 2021 | -1.01K% |
| March 31, 2021 | -881.8% |
| December 31, 2020 | -759.8% |
| September 30, 2020 | -655.2% |
| June 30, 2020 | -685.0% |
| March 31, 2020 | -448.1% |
| December 31, 2019 | -719.8% |
| September 30, 2019 | -1.03K% |
| June 30, 2019 | -2.28K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-3.46K%
Minimum
Jun 2024
-448.1%
Maximum
Mar 2020
-1.61K%
Average
-1.82K%
Median
Dec 2022
Profit Margin (Quarterly) Benchmarks
| Sarepta Therapeutics Inc | 7.19% |
| Natera Inc | -9.06% |
| Entrada Therapeutics Inc | -71.70% |
| Alnylam Pharmaceuticals Inc | -22.27% |
| Catalyst Pharmaceuticals Inc | 34.10% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -34.78% |
| Return on Assets | -30.70% |
| Return on Invested Capital | -34.78% |
| Operating Margin (Quarterly) | -4.04K% |
| Return on Net Operating Assets | -868.9% |